GlassScriptPhysician profile
Rachel Rambler
NPI 1104710839
$1,826.15
in general payments reported to CMS, 2019-2025
16 companies · $1,826 in 2025
The $1,826 reported for 2025 was more than what 92% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $1,826.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,758 · Education: $68.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,758.15 |
| Education | $68.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $771.65 | 2025 | Erleada, Carvykti, Rybrevant |
| Janssen Scientific Affairs, LLC | $372.14 | 2025 | Erleada |
| Dentsply Ih Ab | $116.30 | 2025 | Lofric |
| Sumitomo Pharma America, INC. | $86.97 | 2025 | Gemtesa |
| Novartis Pharmaceuticals Corporation | $69.15 | 2025 | |
| Tolmar, INC. | $65.86 | 2025 | Jatenzo, Eligard |
| Urogen Pharma, INC. | $55.36 | 2025 | |
| Abbvie INC. | $49.32 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $38.52 | 2025 | Lynparza |
| Olympus America INC. | $37.47 | 2025 | Itind System |
| Smith+Nephew, INC. | $32.09 | 2025 | Stravix Pl, Stravix |
| Merck Sharp & Dohme LLC | $31.76 | 2025 | Keytruda |
| Janssen Pharmaceuticals, INC | $29.15 | 2025 | Erleada |
| Calyxo, INC. | $28.80 | 2025 | Cvac Aspiration System |
| Bayer Healthcare Pharmaceuticals INC. | $26.37 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $15.24 | 2025 | Adstiladrin |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachel Rambler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.